Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Consulting agrmnt
Appointed COO
Appointed director
CC transcript
MOMENTA PHARMACEUTICALS INC (MNTA) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/10/2020 SC 13G/A FMR LLC reports a 0% stake in MOMENTA PHARMACEUTICALS INC
10/13/2020 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/01/2020 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
10/01/2020 8-K Quarterly results
10/01/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/01/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/01/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/01/2020 GN Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & Johnson
09/23/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/23/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
09/16/2020 GN Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Rosetta Stone, Momenta, Jernigan, and Varian on behalf of Stockholders and Encourages Investors to Contact the Firm
09/15/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/15/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
09/15/2020 GN Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson & Johnson
09/04/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/04/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
09/02/2020 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
09/02/2020 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
09/01/2020 GN Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Momenta Pharmaceuticals, Inc., Principia Biopharma Inc., and Yintech Investment Holdings Limited
08/20/2020 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy